warnings
Warnings For external use only
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
| Harmonized routes |
|---|
| TOPICAL |
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M020 | openfda.application_number | |
| brand name | CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen | openfda.brand_name | |
| generic name | HOMOSALATE, MERADIMATE, OCTINOXATE, ZINC OXIDE, AND OCTOCRYLENE | openfda.generic_name | |
| manufacturer name | L'Oreal USA Products, Inc. | openfda.manufacturer_name | |
| ndc | package | 49967-015-02 | openfda.package_ndc |
| ndc | package | 49967-015-04 | openfda.package_ndc |
| ndc | package | 49967-015-05 | openfda.package_ndc |
| ndc | package | 49967-015-01 | openfda.package_ndc |
| ndc | package | 49967-015-03 | openfda.package_ndc |
| ndc | package | 49967-015-06 | openfda.package_ndc |
| ndc | product | 49967-015 | openfda.product_ndc |
| ndc11 | package | 49967001503 | derived:openfda.package_ndc |
| ndc11 | package | 49967001502 | derived:openfda.package_ndc |
| ndc11 | package | 49967001505 | derived:openfda.package_ndc |
| ndc11 | package | 49967001504 | derived:openfda.package_ndc |
| ndc11 | package | 49967001501 | derived:openfda.package_ndc |
| ndc11 | package | 49967001506 | derived:openfda.package_ndc |
| spl id | 9e408aae-0e5e-476f-aefe-3b813f3934b7 | id | |
| spl set id | 2138f86b-3937-4c2b-9568-d40a745b637d | set_id | |
| unii | 5A68WGF6WM | openfda.unii | |
| unii | V06SV4M95S | openfda.unii | |
| unii | SOI2LOH54Z | openfda.unii | |
| unii | 4Y5P7MUD51 | openfda.unii | |
| unii | J9QGD60OUZ | openfda.unii |
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse event summaries are temporarily unavailable. Other product information remains available.